Trosolwyg
Rwy'n Reolwr Ymchwil Cyswllt a Threial yn yr isadran Ymchwil Heintiau, Llid ac Imiwnedd (I3) yn y Ganolfan Treialon Ymchwil, Coleg y Gwyddorau Biofeddygol a Bywyd, Prifysgol Caerdydd.
Mae fy niddordebau ymchwil yn rhychwantu themâu I3, ar ôl gweithio ar yr astudiaethau canlynol; BARDDONOL, CYFLYMDER, CYMELL, THESEUS a PriMUS; Astudiaethau a threialon - Canolfan Ymchwil Treialon - Prifysgol Caerdydd.
Mae gennyf wybodaeth a phrofiad helaeth o fethodoleg a llywodraethu treialon o fewn y lleoliadau gofal sylfaenol a gofal eilaidd.
Cyhoeddiad
2024
- Sewell, B. et al. 2024. Cost-effectiveness of C-reactive protein point of care testing for safely reducing antibiotic consumption for acute exacerbations of chronic obstructive pulmonary disease as part of the multicentre, parallel-arm, open, individually randomised, controlled PACE trial. BMJ Open 14(11), article number: e084144. (10.1136/bmjopen-2024-084144)
- Hasan, S. B. et al. 2024. Feasibility of daily pain measurement using text messages in Hidradenitis Suppurativa clinical trials; Data from THESEUS study. British Journal of Dermatology 190(5), pp. 775-777., article number: ljae057. (10.1093/bjd/ljae057)
- Ingram, J. R. et al. 2024. Treatment of hidradenitis suppurativa evaluation study (THESEUS): a prospective cohort study. British Journal of Dermatology 190(3), pp. 382-391. (10.1093/bjd/ljad388)
- Edwards, A. et al. 2024. Development of a clinical decision support tool for Primary care Management of lower Urinary tract Symptoms in men: the PriMUS study. Health Technology Assessment
2023
- Ingram, J. R. et al. 2023. Treatment of hidradenitis suppurativa evaluation study: the THESEUS prospective cohort study. Health Technology Assessment 27, article number: 30. (10.3310/HWNM2189)
- Leighton, P. et al. 2023. Research priorities in the management of Hidradenitis Suppurativa [Research Letter]. British Journal of Dermatology 189(3), pp. 343-345. (10.1093/bjd/ljad152)
2021
- Gillespie, D. et al. 2021. Associations with antibiotic prescribing for acute exacerbation of COPD in primary care: secondary analysis of a randomised controlled trial. British Journal of General Practice 71(705), pp. e266-e272. (10.3399/BJGP.2020.0823)
2019
- Butler, C. C. et al. 2019. C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations. New England Journal of Medicine 381, pp. 111-120. (10.1056/NEJMoa1803185)
2017
- Butler, C. C. et al. 2017. Variations in presentation, management, and patient outcomes of urinary tract infection: a prospective four-country primary care observational cohort study. British Journal of General Practice 67(665), pp. e830-e841. (10.3399/bjgp17X693641)
- Bates, J. et al. 2017. General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled trial. Trials 18, article number: 422. (10.1186/s13063-017-2144-8)
Articles
- Sewell, B. et al. 2024. Cost-effectiveness of C-reactive protein point of care testing for safely reducing antibiotic consumption for acute exacerbations of chronic obstructive pulmonary disease as part of the multicentre, parallel-arm, open, individually randomised, controlled PACE trial. BMJ Open 14(11), article number: e084144. (10.1136/bmjopen-2024-084144)
- Hasan, S. B. et al. 2024. Feasibility of daily pain measurement using text messages in Hidradenitis Suppurativa clinical trials; Data from THESEUS study. British Journal of Dermatology 190(5), pp. 775-777., article number: ljae057. (10.1093/bjd/ljae057)
- Ingram, J. R. et al. 2024. Treatment of hidradenitis suppurativa evaluation study (THESEUS): a prospective cohort study. British Journal of Dermatology 190(3), pp. 382-391. (10.1093/bjd/ljad388)
- Edwards, A. et al. 2024. Development of a clinical decision support tool for Primary care Management of lower Urinary tract Symptoms in men: the PriMUS study. Health Technology Assessment
- Ingram, J. R. et al. 2023. Treatment of hidradenitis suppurativa evaluation study: the THESEUS prospective cohort study. Health Technology Assessment 27, article number: 30. (10.3310/HWNM2189)
- Leighton, P. et al. 2023. Research priorities in the management of Hidradenitis Suppurativa [Research Letter]. British Journal of Dermatology 189(3), pp. 343-345. (10.1093/bjd/ljad152)
- Gillespie, D. et al. 2021. Associations with antibiotic prescribing for acute exacerbation of COPD in primary care: secondary analysis of a randomised controlled trial. British Journal of General Practice 71(705), pp. e266-e272. (10.3399/BJGP.2020.0823)
- Butler, C. C. et al. 2019. C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations. New England Journal of Medicine 381, pp. 111-120. (10.1056/NEJMoa1803185)
- Butler, C. C. et al. 2017. Variations in presentation, management, and patient outcomes of urinary tract infection: a prospective four-country primary care observational cohort study. British Journal of General Practice 67(665), pp. e830-e841. (10.3399/bjgp17X693641)
- Bates, J. et al. 2017. General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled trial. Trials 18, article number: 422. (10.1186/s13063-017-2144-8)